Evolus (EOLS) Change in Account Payables (2017 - 2026)
Evolus (EOLS) reported Change in Account Payables of -$7.6 million for Q1 2026, down 261.14% on a YoY basis from $4.7 million in Q1 2025, and down 471.9% quarter-over-quarter from $2.0 million in Q4 2025.
Evolus (EOLS) Change in Account Payables (2017 - 2026) Analysis & Trends
Evolus has reported Change in Account Payables for 10 years, with the latest figure at -$7.6 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables fell 261.14% year-over-year to -$7.6 million; the trailing twelve-month figure through Mar 2026 stood at -$2.2 million (down 153.0% YoY), and the FY2025 full-year result was $10.1 million, up 2483.89% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$7.6 million, down from $2.0 million in the prior quarter.
- The five-year high for Change in Account Payables was $4.7 million in Q1 2025, with the low at -$7.6 million in Q1 2026.
- Historically, Change in Account Payables has averaged $166823.5 across 5 years, with a median of $909000.0 in 2024.
- Annual changes were most pronounced in 2022 — Change in Account Payables jumped 1028.57% — and 2024, when it plunged 508.13%.
- Evolus' Change in Account Payables stood at -$1.4 million in 2022, then sank by 323.8% to -$5.8 million in 2023, then jumped by 50.24% to -$2.9 million in 2024, then jumped by 170.82% to $2.0 million in 2025, then slumped by 471.9% to -$7.6 million in 2026.
- The last three Change in Account Payables figures came in at -$7.6 million (Q1 2026), $2.0 million (Q4 2025), and $4.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 62.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 167.64 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 190,000.00 |
| 10 | Evolus | 437.40 Mn | 387.61 Mn | 48.90 Mn | -7.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.61 Mn |
| Mar 31, 2026 | -7.61 Mn |
| Dec 31, 2025 | 2.05 Mn |
| Dec 31, 2025 | 2.05 Mn |
| Sep 30, 2025 | 4.11 Mn |
| Sep 30, 2025 | 4.11 Mn |
| Jun 30, 2025 | -777,000.00 |
| Jun 30, 2025 | -777,000.00 |
| Mar 31, 2025 | 4.72 Mn |
| Mar 31, 2025 | 4.72 Mn |
| Dec 31, 2024 | -2.89 Mn |
| Dec 31, 2024 | -2.89 Mn |
| Sep 30, 2024 | 3.53 Mn |
| Sep 30, 2024 | 3.53 Mn |
| Jun 30, 2024 | -1.16 Mn |
| Jun 30, 2024 | -1.16 Mn |
| Mar 31, 2024 | 909,000.00 |
| Mar 31, 2024 | 909,000.00 |
| Dec 31, 2023 | -5.81 Mn |
| Dec 31, 2023 | -5.81 Mn |